These results demonstrated similar neurological disease in mAb treated mice as IFN-deficient models previously mentioned, suggesting antibody blockade against IFNAR may be a suitable model to further study neurological damage caused by ZIKV infections using transgenic mice of the same background. The gene discussed is IFNAR1; the disease is nervous system disorder.